Skip to main content
Daniel Bauer, MD, Pediatric Hematology & Oncology, Boston, MA

DanielEBauerMDPhD

Pediatric Hematology & Oncology • Boston, MA

Pediatric Anemia and Red Blood Cell Hematology

Staff Physician, Boston Children's Hospital and Dana-Farber Cancer Institute / Associate Professor of Pediatrics, Harvard Medical School

Join to view full profile

Dr. Bauer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bauer's full profile

Already have an account?

  • Office

    450 Brookline Ave
    Boston, MA 02215
    Phone+1 617-632-3000
    Fax+1 617-632-4773

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2008 - 2012
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2006 - 2008
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2006

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2025
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Journal Articles

  • CRISPRO: Identification of Functional Protein Coding Sequences Based on Genome Editing Dense Mutagenesis  
    Daniel Bauer, MD, BioMed Central

Abstracts/Posters

  • Durable and Robust Fetal Globin Induction without Anemia in Rhesus Monkeys Following Autologous Hematopoietic Stem Cell Transplant with BCL11A Erythroid Enhancer Editing
    Daniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • CRISPR-Cas9 Screen Identifies XPO7 As a Potential Therapeutic Target for TP53-Mutated AML
    Daniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Therapeutic Base Editing of Human Hematopoietic Stem Cells
    Daniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Transcriptional Signaling Centers Govern Human Erythropoiesis and Harbor Genetic Variations of Red Blood Cell Traits 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Opportunities for Scientists in Hematology: Nothing Basic About Discovery 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Press Mentions

  • Boston Woman Adopts 3 Girls That Have Same Incurable Blood Disease She Has: ‘It’s a Miracle We Found Each Other’
    Boston Woman Adopts 3 Girls That Have Same Incurable Blood Disease She Has: ‘It’s a Miracle We Found Each Other’June 12th, 2017
  • Patients with Sickle Cell Disease Urge FDA to Greenlight Landmark Gene-Editing Treatment
    Patients with Sickle Cell Disease Urge FDA to Greenlight Landmark Gene-Editing TreatmentNovember 2nd, 2023
  • Potential Cure for Sickle Cell Clears Hurdle for Approval
    Potential Cure for Sickle Cell Clears Hurdle for ApprovalNovember 2nd, 2023
  • Join now to see all

Dr. Daniel Bauer, Dr. Daniel Bauer, MD, Dr. D Bauer, Dr. Daniel E Bauer